Dyne Therapeutics, Inc
NASDAQ:DYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dyne Therapeutics, Inc
NASDAQ:DYN
|
US |
|
T
|
Thanapiriya PCL
SET:TNP
|
TH |
|
Intiland Development Tbk PT
IDX:DILD
|
ID |
|
L
|
Lockheed Martin Corp
F:LOM
|
US |
|
C
|
CES Energy Solutions Corp
OTC:CESDF
|
CA |
|
C
|
CMO PCL
SET:CMO
|
TH |
|
C
|
Chin Huay PCL
SET:CH
|
TH |
|
Frontier Developments PLC
LSE:FDEV
|
UK |
|
P
|
Precise Corporation PCL
SET:PCC
|
TH |
Intrinsic Value
Is DYN undervalued or overvalued?
See the intrinsic value estimate for Dyne Therapeutics, Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
DYN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with DYN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Dyne Therapeutics Does
Dyne Therapeutics is a clinical-stage biotechnology company focused on diseases where muscle cells are the main problem, especially rare inherited muscle disorders. It is building medicines that are designed to reach skeletal and heart muscle more effectively than older treatments, using its own delivery technology to carry drug molecules into the right tissues.
- Headquarters
- United States of America US
- Employees
- 258
- IPO date
- Sep 17, 2020
Earnings Waterfall
Dyne Therapeutics, Inc
The intrinsic value for Dyne Therapeutics, Inc (DYN) under the Base Case is hidden USD.
Compared with the current market price of 15.29 USD, the stock appears hidden.